Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis
Article first published online: 11 JUN 2009
© 2009 British Society for Immunology
Clinical & Experimental Immunology
Volume 158, Issue 1, pages 45–54, October 2009
How to Cite
Esquivel-Solís, H., Quiñones-Falconi, F., Zarain-Herzberg, A., Amieva-Fernández, R. I. and López-Vidal, Y. (2009), Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis. Clinical & Experimental Immunology, 158: 45–54. doi: 10.1111/j.1365-2249.2009.03985.x
- Issue published online: 2 SEP 2009
- Article first published online: 11 JUN 2009
- Accepted for publication 3 June 2009
- 1The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 2003; 83:4–14..
- 2How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001; 1:20–30..
- 3Host innate immune response to Mycobacterium tuberculosis. Immunol J Clin 2007; 27:347–62., .
- 4Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J Infect Dis 2005; 192:89–97., , et al.
- 5Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts. Am J Respir Crit Care Med 2006; 173:238–45., , , , , .
- 6Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 2002; 61 (Suppl. 2):ii54–8..
- 7Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. J Immunol 1998; 160:4490–9., , et al.
- 8An essential role for interferon gamma in resistance to infection. J Exp Med 1993; 178:2249–54., , , , , .
- 9Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004; 364:2113–21., , et al.
- 10Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94:5243–8., , , , , .
- 11Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243–7., , , , , .
- 12Pharmacological modulation of the IFNgamma-induced accessory function of alveolar macrophages and peripheral blood monocytes. Inflamm Res 1999; 48:662–8., , , .
- 13Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol 2002; 3:859–66., , et al.
- 14Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 2002; 23:96–101., , , .
- 15Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2. Cell Microbiol 2007; 9:382–96., , et al.
- 16ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell Microbiol 2008; 10:741–54., , et al.
- 17Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990; 145:149–54., , , , , .
- 18Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis (Edinb) 2004; 84:375–85., , , , .
- 19Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol 2000; 165:1479–85., , et al.
- 20High level of interferon gamma in tuberculous pleural effusion. Chest 1988; 93:308–11., , , , , .
- 21Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996; 64:1351–6., , , , .
- 22Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med 1994; 149:989–93., , et al.
- 23Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993; 61:3482–9., , , , , .
- 24Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages. Clin Vaccine Immunol 2007; 14:1279–84., , et al.
- 25Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro. Infect Immun 1997; 65:4850–7., , , , .
- 26Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126:131–8., , , , , .
- 27Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993; 150:2920–30..
- 28Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 2006; 176:3019–27., , , , .
- 29The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 2005; 202:987–99., , et al.
- 30Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infect Immun 1998; 66:2769–77., .
- 31Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J Immunol 2005; 175:1785–94., , , .
- 32Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J Immunol 2006; 176:3010–18., , , , , .
- 33Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun 1985; 50:1–8., , , .
- 34Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 1986; 59:333–8., , , .
- 35Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol 1997; 181:31–8., , et al.
- 36Functional and genetic assessment of IFN-gamma receptor in patients with clinical tuberculosis. Int J Tuberc Lung Dis 2004; 8:1221–7., , et al.
- 37Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect Immun 2003; 71:2058–64., , et al.
- 38Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol 2004; 172:6272–80., , et al.
- 39Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol 1999; 163:3898–906., , , .
- 40Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol 2007; 82:237–43., , , .
- 41Complex roles of Stat1 in regulating gene expression. Oncogene 2000; 19:2619–27., , , .
- 42Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 2001; 98:6674–9., , , , , .
- 43A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 2007; 282:938–46., , et al.
- 44IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 2006; 24:563–74., , et al.
- 45Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu Rev Genomics Hum Genet 2007; 8:163–92., , , .
- 46Fos/AP-1 proteins in bone and the immune system. Immunol Rev 2005; 208:126–40., .
- 47Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr 2007; 98 (Suppl. 1):S121–6., , , .
- 48CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002; 46:2578–86., , et al.
- 49CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med 1999; 37:209–13., .
- 50Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 2006; 79:285–93., , , , .
- 51Expression of GM1, a marker of lipid rafts, defines two subsets of human monocytes with differential endocytic capacity and lipopolysaccharide responsiveness. Immunology 2007; 120:536–43., , .
- 52Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74:2527–34., , .